← Back to Search

PrEPmate for Human Immunodeficiency Virus Infection (PCORI PrEP Trial)

N/A

Recruiting

Research Sponsored by Public Health Foundation Enterprises, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up dbs measured through 12 months

Awards & highlights

PCORI PrEP Trial Summary

This trial will compare how well text messaging and a mobile app help people take HIV PrEP as prescribed.

Eligible Conditions

Human Immunodeficiency Virus (HIV) Infection
Sexually Transmitted Infections

PCORI PrEP Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ dbs measured through 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~dbs measured through 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and dbs measured through 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Patient engagement

PrEP adherence as measured by tenofovir diphosphate levels in dried blood spots

Satisfaction with medical care

Secondary outcome measures

Adherence self-efficacy

PrEP continuation based on medication refills

Sexual satisfaction

PCORI PrEP Trial Design

2Treatment groups

Experimental Treatment

Group I: PrEPmateExperimental Treatment1 Intervention

Participants randomized to this study arm will receive the PrEPmate mHealth intervention (bi-directional text messaging with PrEP navigators/clinic staff) to support PrEP adherence and continuation.

Group II: Dot Diary mobile applicationExperimental Treatment1 Intervention

Participants randomized to this study arm will download and use the Dot Diary mobile application on a personal device, to support PrEP adherence and continuation.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MiamiOTHER

899 Previous Clinical Trials

409,432 Total Patients Enrolled

Whitman-Walker HealthUNKNOWN

San Francisco AIDS FoundationUNKNOWN

2 Previous Clinical Trials

448 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the cumulative amount of enrollees participating in this experiment?

"300 willing and eligible participants are sought for this medical trial. Potential candidates can register at Whitman-Walker Health in Washington, District of Columbia or University of Miami in Miami, Florida."

Answered by AI

Are there any remaining vacancies for participants in this research?

"Affirmative. Clinicaltrials.gov attests that this research is still recruiting, as the study was first posted on July 21st 2021 and has been updated most recently on September 27th 2022. 300 eligible patients need to be enrolled across 3 different medical centers."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention

Albert Liu 2021. "Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04855773.